ALLG NBCR
Australasian Leukaemia and Lymphoma Group National Blood Cancer Registry
Trial summary:
The Australasian Leukaemia and Lymphoma Group (ALLG) National Blood Cancer Registry (NBCR) is an ongoing collection of information and patient samples for patients with suspected, or known, or diagnosed blood cancer.
Receptor status / problem studied:
all Leukaemia and all Lymphoma
Inclusion criteria
- Male or female with a suspected, or known, or diagnosed blood cancer
- Aged 15 and over
- Has provided written informed consent
Exclusion criteria
Open for recruitment
Trial Title
ALLG NBCR
Diagnosis
Leukaemia
Type of trial
Collaborative
Type of treatement
Haematology
Phase
Registry
Locations
Investigators
Principal Investigator